These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1984680)

  • 1. Humoral immune responses to gag and env proteins from human immunodeficiency virus type 1 in hemophiliac patients.
    Kinney JS; Conway JH; Hilgartner MW; Clayman B; Mayur K; Yolken RH; Viscidi RP
    Am J Hematol; 1991 Jan; 36(1):35-41. PubMed ID: 1984680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential changes in antibody levels to the env and gag antigens in human immunodeficiency virus infected subjects.
    Manca N; di Marzo Veronese F; Ho DD; Gallo RC; Sarngadharan MG
    Eur J Epidemiol; 1987 Jun; 3(2):96-102. PubMed ID: 3497054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between humoral responses to HIV gag and env proteins at seroconversion and clinical outcome of HIV infection.
    Cheingsong-Popov R; Panagiotidi C; Bowcock S; Aronstam A; Wadsworth J; Weber J
    BMJ; 1991 Jan; 302(6767):23-6. PubMed ID: 1899349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the recombinant chimera proteins, LacZ-Env and Gag-Env, for immunological studies on HIV-1 infection.
    Morimoto M; Saitoh A; Ueba N; Nakata A; Shinagawa H
    AIDS Res Hum Retroviruses; 1993 Oct; 9(10):971-8. PubMed ID: 7506555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of recombinant human adenovirus-human immunodeficiency virus vaccines in chimpanzees.
    Natuk RJ; Lubeck MD; Chanda PK; Chengalvala M; Wade MS; Murthy SC; Wilhelm J; Vernon SK; Dheer SK; Mizutani S
    AIDS Res Hum Retroviruses; 1993 May; 9(5):395-404. PubMed ID: 8318268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased T cell breadth and antibody response elicited in prime-boost regimen by viral vector encoded homologous SIV Gag/Env in outbred CD1 mice.
    Andersson AC; Holst PJ
    J Transl Med; 2016 Dec; 14(1):343. PubMed ID: 27998269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent inhibition of Gag cellular immunity by Env in SIV/HIV DNA vaccinated macaques.
    Valentin A; Li J; Rosati M; Kulkarni V; Patel V; Jalah R; Alicea C; Reed S; Sardesai N; Berkower I; Pavlakis GN; Felber BK
    Hum Vaccin Immunother; 2015; 11(8):2005-11. PubMed ID: 26125521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study on correlation between the decrease in anti-P17 antibody level and progression to AIDS in asymptomatic carriers of HIV.
    Choudhury AM; Yamada O; Wakamiya N; Kurimura T
    Microbiol Immunol; 1992; 36(8):833-40. PubMed ID: 1474934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of HIV-1 Env and Gag in baboons using a DNA prime/protein boost regimen.
    Leung L; Srivastava IK; Kan E; Legg H; Sun Y; Greer C; Montefiori DC; zur Megede J; Barnett SW
    AIDS; 2004 Apr; 18(7):991-1001. PubMed ID: 15096801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-env and anti-gag antibodies in subjects infected with the human immunodeficiency virus].
    Sanz del Forcallo FJ; García Delgado R; Ortiz Maslloréns F
    Rev Clin Esp; 1989 Dec; 185(9):443-7. PubMed ID: 2696006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
    Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
    J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid reconstitution of humoral immunity against cytomegalovirus but not HIV following highly active antiretroviral therapy.
    Deayton JR; Sabin CA; Britt WB; Jones IM; Wilson P; Johnson MA; Griffiths PD; Emery VC
    AIDS; 2002 Nov; 16(16):2129-35. PubMed ID: 12409733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV.
    Ourmanov I; Brown CR; Moss B; Carroll M; Wyatt L; Pletneva L; Goldstein S; Venzon D; Hirsch VM
    J Virol; 2000 Mar; 74(6):2740-51. PubMed ID: 10684290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells.
    Quinnan GV; Yu XF; Lewis MG; Zhang PF; Sutter G; Silvera P; Dong M; Choudhary A; Sarkis PT; Bouma P; Zhang Z; Montefiori DC; Vancott TC; Broder CC
    J Virol; 2005 Mar; 79(6):3358-69. PubMed ID: 15731230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte responses: a predominant gag-specific response is associated with nonprogressive infection.
    Pontesilli O; Klein MR; Kerkhof-Garde SR; Pakker NG; de Wolf F; Schuitemaker H; Miedema F
    J Infect Dis; 1998 Oct; 178(4):1008-18. PubMed ID: 9806028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS.
    Rivière Y; McChesney MB; Porrot F; Tanneau-Salvadori F; Sansonetti P; Lopez O; Pialoux G; Feuillie V; Mollereau M; Chamaret S
    AIDS Res Hum Retroviruses; 1995 Aug; 11(8):903-7. PubMed ID: 7492437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic importance of antibodies to human immunodeficiency virus by recombinant immunoassay and Western blot techniques in HIV antibody-positive hemophiliacs.
    Ragni MV; O'Brien TA; Reed D; Spero JA; Lewis JH
    AIDS Res Hum Retroviruses; 1988 Jun; 4(3):223-31. PubMed ID: 3165003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody responses in early human immunodeficiency virus type 1 infection in hemophiliacs.
    Chou MJ; Lee TH; Hatzakis A; Mandalaki T; McLane MF; Essex M
    J Infect Dis; 1988 Apr; 157(4):805-11. PubMed ID: 3346572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus infection in hemophiliac patients. A three-year prospective evaluation.
    Daul CB; deShazo RD; Andes WA
    Am J Med; 1988 May; 84(5):801-9. PubMed ID: 3163229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-existing immunity to pathogenic Listeria monocytogenes does not prevent induction of immune responses to feline immunodeficiency virus by a novel recombinant Listeria monocytogenes vaccine.
    Stevens R; Lavoy A; Nordone S; Burkhard M; Dean GA
    Vaccine; 2005 Feb; 23(12):1479-90. PubMed ID: 15670884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.